Gilbert H.  Kliman net worth and biography

Gilbert Kliman Biography and Net Worth

Director of Doximity
Gil joined InterWest in 1996. As Managing Partner of the firm and the leader of InterWest’s Healthcare investment team, he invests in a broad array of healthcare opportunities, with a special interest in ophthalmology, digital health, and AI/robotics. Gil pioneered InterWest’s highly successful ophthalmology franchise. He was an early investor in Avedro, Glaukos, LenSx, and IntraLase, all category-creating ophthalmic companies that became standard-of-care for eye surgery around the world.

As a successful digital health investor, Gil built this important franchise for InterWest over the last twenty years through multiple companies. He was the founding institutional investor in Doximity, helping to build it into the leading digital network for physicians, engaging over 80% of U.S. doctors, with over one million users. Gil and InterWest supported Doximity’s June 2021 blockbuster IPO, which subsequently generated the largest investment return in InterWest’s history. Prior to that, he led the Series A of Epocrates, the first mobile application for physicians, serving on the board through its 2011 IPO and continuing as an investor through the 2013 acquisition by athenahealth.

He is a board member of Doximity (NYSE: DOCS), Glaukos (NYSE: GKOS), and a former board member and lead investor in Avedro (NASDAQ: AVDR, acquired by Glaukos), Epocrates (NASDAQ: EPOC, acquired by athenahealth), LenSx Lasers (acquired by Alcon), IntraLase (NASDAQ: ILSE, acquired by AMO), Neuronetics (NASDAQ: STIM), Restoration Robotics (NASDAQ: VERO, acquired by Venus Concept), and GoCheck.

Gil also serves as an independent board member of STAAR Surgical (NASDAQ: STAA), a leading ophthalmology company commercializing the EVO implantable contact lens for nearsightedness, and Orbis International, a global not-for-profit organization focused on preventing blindness. He is also a co-founder and program director of Eyecelerator, a first-of-kind ophthalmology innovation conference supported by a joint venture of the American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery. Its mission is to spur innovation in the ophthalmology sector by connecting scientific talent and entrepreneurs advancing eye care with mission-driven investors and business partners who can support go-to-market success. Previously, he helped to launch the Ophthalmology Innovation Summit (OIS), an ophthalmology business conference where he was an advisor and founding co-chairman from 2009 to 2019.

A former practicing eye surgeon, Gil completed an ophthalmology residency at Wills Eye Hospital and a retina fellowship at Massachusetts Eye and Ear Infirmary as a Heed Foundation fellow. He has a BA from Harvard University, an MD from the University of Pennsylvania and an MBA from Stanford University.

What is Gilbert H. Kliman's net worth?

The estimated net worth of Gilbert H. Kliman is at least $1.55 million as of September 9th, 2024. Mr. Kliman owns 32,336 shares of Doximity stock worth more than $1,552,128 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Kliman may own. Learn More about Gilbert H. Kliman's net worth.

How do I contact Gilbert H. Kliman?

The corporate mailing address for Mr. Kliman and other Doximity executives is , , . Doximity can also be reached via phone at 650-549-4330 and via email at [email protected]. Learn More on Gilbert H. Kliman's contact information.

Has Gilbert H. Kliman been buying or selling shares of Doximity?

Gilbert H. Kliman has not been actively trading shares of Doximity during the last ninety days. Most recently, Gilbert H. Kliman sold 826 shares of the business's stock in a transaction on Friday, February 25th. The shares were sold at an average price of $59.00, for a transaction totalling $48,734.00. Learn More on Gilbert H. Kliman's trading history.

Who are Doximity's active insiders?

Doximity's insider roster includes Anna Bryson (CFO), Timothy Cabral (Director), Paul Jorgensen (CRO), Joseph Kleine (Insider), Gilbert Kliman (Director), Craig Overpeck (Insider), Kevin Spain (Director), Kira Wampler (Director), and Phoebe Yang (Director). Learn More on Doximity's active insiders.

Are insiders buying or selling shares of Doximity?

In the last twelve months, insiders at the sold shares 12 times. They sold a total of 91,951 shares worth more than $2,844,642.74. The most recent insider tranaction occured on August, 9th when CFO Anna Bryson sold 30,000 shares worth more than $1,050,000.00. Insiders at Doximity own 37.4% of the company. Learn More about insider trades at Doximity.

Information on this page was last updated on 8/9/2024.

Gilbert H. Kliman Insider Trading History at Doximity

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/25/2022Sell826$59.00$48,734.00View SEC Filing Icon  
2/23/2022Sell29,174$56.09$1,636,369.66View SEC Filing Icon  
12/7/2021Sell14,892$62.60$932,239.20View SEC Filing Icon  
12/3/2021Sell2,000$65.82$131,640.00View SEC Filing Icon  
See Full Table

Gilbert H. Kliman Buying and Selling Activity at Doximity

This chart shows Gilbert H Kliman's buying and selling at Doximity by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Doximity Company Overview

Doximity logo
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $48.00
Low: $47.66
High: $50.14

50 Day Range

MA: $44.47
Low: $39.32
High: $61.25

2 Week Range

Now: $48.00
Low: $22.96
High: $61.75

Volume

2,675,242 shs

Average Volume

1,750,025 shs

Market Capitalization

$8.96 billion

P/E Ratio

55.17

Dividend Yield

N/A

Beta

1.3